Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Mundipharma Research Limited
Scientific Title
A Randomised, Open Label, Multi-centre, Phase III Study to Investigate the Efficacy of Bendamustine Compared to Treatment of Physician's Choice in the Treatment of Subjects With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab